Friday, 3 December 2021

UK Approves New Sotrovimab Drug Could Work Against Omicron

UK approves new Sotrovimab drug that could work against Omicron; "good news" emerges in early data on new variant; nothing to stop festive parties and no guidance on who you should kiss at Christmas, according to UK government.

According to report, the UK has approved another antibody treatment for people with Covid that cuts the risk of severe illness.

It's called sotrovimab, and scientists say preliminary checks suggest it should work well even against new variants such as Omicron.

The drug, given in a drip into a vein, binds to the virus to stop it entering our cells.

In a clinical trial, a single dose reduced the risk of hospitalisation and death by 79% in high risk adults.

It is the second drug of its kind - a monoclonal antibody treatment - that UK regulators have approved.

 

No comments:

Post a Comment